Sagimet Biosciences Inc. - Series A Common Stock, par value $0.0001 per share (SGMT)

86 filings reported holding SGMT - Sagimet Biosciences Inc. - Series A Common Stock, par value $0.0001 per share as of Q1 2024.
Sagimet Biosciences Inc. - Series A Common Stock, par value $0.0001 per share (SGMT) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 22.6M shares of 31.3M outstanding shares and own 72.28% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (2.67M shares), BlackRock Inc. (2.03M shares), NEA Management Company, LLC (2M shares), Blue Owl Capital Holdings LP (1.67M shares), BAKER BROS. ADVISORS LP (1.38M shares), VANGUARD GROUP INC (1.14M shares), JPMORGAN CHASE & CO (1.12M shares), Alyeska Investment Group, L.P. (1.1M shares), RTW INVESTMENTS, LP (999K shares), and PFM Health Sciences, LP (803K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.